Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lawrence

Showing results (251-260 of 275) with videos related to

Pageof 28
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)N Lawrence, A Martin, G Toner, et al.
The Journal of Rheumatology|October 13, 2009
Progress in measurement instruments for acute and chronic gout studiesRebecca Grainger, William J Taylor, Nicola Dalbeth, et al.
Science (New York, N.Y.)|September 9, 1983
Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacsM Essex, M F McLane, T H Lee, et al.
The Journal of Rheumatology|July 5, 2011
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research prioritiesNicola Dalbeth, Fiona M McQueen, Jasvinder A Singh, et al.
The Journal of Rheumatology|July 5, 2011
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trialsWilliam J Taylor, Jasvinder A Singh, Kenneth G Saag, et al.
JTO Clinical and Research Reports|September 30, 2021
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA GenotypingMarissa N Lawrence, Rubii M Tamen, Pablo Martinez, et al.
Seminars in Arthritis and Rheumatism|March 24, 2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome setMelanie B Morillon, Alexander Nørup, Jasvinder A Singh, et al.
The Journal of Rheumatology|December 17, 2013
OMERACT endorsement of measures of outcome for studies of acute goutJasvinder A Singh, William J Taylor, Nicola Dalbeth, et al.
The Journal of Rheumatology|July 5, 2011
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?Lisa K Stamp, Puja P Khanna, Nicola Dalbeth, et al.
JAMA|August 18, 2011
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trialsJohn S Sundy, Herbert S B Baraf, Robert A Yood, et al.
Pageof 28

Showing results (251-260 of 275) with videos related to

Sort By:
Pageof 28
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)N Lawrence, A Martin, G Toner, et al.
The Journal of Rheumatology|October 13, 2009
Progress in measurement instruments for acute and chronic gout studiesRebecca Grainger, William J Taylor, Nicola Dalbeth, et al.
Science (New York, N.Y.)|September 9, 1983
Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacsM Essex, M F McLane, T H Lee, et al.
The Journal of Rheumatology|July 5, 2011
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research prioritiesNicola Dalbeth, Fiona M McQueen, Jasvinder A Singh, et al.
The Journal of Rheumatology|July 5, 2011
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trialsWilliam J Taylor, Jasvinder A Singh, Kenneth G Saag, et al.
JTO Clinical and Research Reports|September 30, 2021
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA GenotypingMarissa N Lawrence, Rubii M Tamen, Pablo Martinez, et al.
Seminars in Arthritis and Rheumatism|March 24, 2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome setMelanie B Morillon, Alexander Nørup, Jasvinder A Singh, et al.
The Journal of Rheumatology|December 17, 2013
OMERACT endorsement of measures of outcome for studies of acute goutJasvinder A Singh, William J Taylor, Nicola Dalbeth, et al.
The Journal of Rheumatology|July 5, 2011
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?Lisa K Stamp, Puja P Khanna, Nicola Dalbeth, et al.
JAMA|August 18, 2011
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trialsJohn S Sundy, Herbert S B Baraf, Robert A Yood, et al.
Pageof 28